CompletedOther29 June 2026

Nu-Med Plus, Inc. to acquire Avid Gold Ltd

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Nu-Med Plus, Inc.
Target
Avid Gold Ltd
Deal value
Not disclosed
Announced
29 June 2026
Status
Completed
Sector
Other
Country
United Kingdom
Consideration
shares, loan-note
What we know

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

2 updates
  1. CompletedClosed

    Nu-Med Plus, Inc. completes acquisition of Avid Gold

    Item 1.01 Entry into a Material Definitive Agreement. The information and disclosures under “ Explanatory Note ” of this Current Report on Form 8-K is incorporated by reference into this Item 1.01 in their entirety. Registration Rights Agreement Following the closing of the Exchange (the “ Closing ”), the Company is required to prepare and file with the Securities and Exchange Commission (the “ SE

    Source
  2. Firm intention

    Nu-Med Plus, Inc. firm intention to acquire Avid Gold Ltd

    Item 1.01 Entry into a Material Definitive Agreement. Share Exchange Agreement On June 29, 2026, Nu-Med Plus, Inc. (the “ Company ”, “ we ” and “ us ”), entered into a Share Exchange Agreement (the “ Exchange Agreement ”) with Avid Gold Ltd, a private limited company formed under the laws of England and Wales (“ Avid Gold ”), and the shareholders of Avid Gold (the “ Avid Gold Shareholders ”). Purs

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Other M&A activity tracked by Exit Mode.

Buyer history

Nu-Med Plus, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive